StocktoriaENDRA Life Sciences Inc. NDRA
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus
Chart by TradingView
2/9
Piotroski F — financial health
-101.64
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$5.8M | -$10.8M | -$10.5M | -$13.2M | -$11.5M |
| Net income | -$7.0M | -$11.5M | -$10.1M | -$13.2M | -$11.2M |
| Operating cash flow | -$5.2M | -$7.4M | -$9.5M | -$12.8M | -$11.1M |
| Free cash flow | -$5.2M | -$7.4M | -$9.6M | -$13.0M | -$11.2M |
| Total assets | $3.9M | $4.5M | $6.8M | $9.3M | $12.9M |
| Total liabilities | $1.6M | $1.9M | $1.1M | $2.1M | $2.1M |
| Shareholders' equity | $2.3M | $2.6M | $5.7M | $7.2M | $10.8M |
| Ratios | |||||
| Return on assets | -182.4% | -258.5% | -148.9% | -142.1% | -87.2% |
| Return on equity | -310.9% | -449.5% | -177.8% | -182.9% | -104.1% |
| Debt / equity | — | 0.00× | 0.00× | 0.00× | 0.05× |
| Current ratio | 1.29 | 5.67 | 3.36 | 3.16 | 7.83 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -101.64 (distress)
- Working capital / assets 0.056
- Retained earnings / assets -28.664
- EBIT / assets -1.495
- Equity / liabilities 1.418
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001681682 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.